TrialJournal of acquired immune deficiency syndromes (1999)2016

The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.

Marc M Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.